Your browser doesn't support javascript.
loading
Guideline for standardized approach in the treatment of the Mal de Debarquement syndrome.
Schoenmaekers, Catho; Jillings, Steven; De Laet, Chloë; Zarowski, Andrzej; Wuyts, Floris L.
Afiliación
  • Schoenmaekers C; Lab for Equilibrium Investigations and Aerospace, University of Antwerp, Wilrijk, Belgium.
  • Jillings S; Lab for Equilibrium Investigations and Aerospace, University of Antwerp, Wilrijk, Belgium.
  • De Laet C; Lab for Equilibrium Investigations and Aerospace, University of Antwerp, Wilrijk, Belgium.
  • Zarowski A; European Institute for ORL-HNS, Sint-Augustinus Hospital, Wilrijk, Belgium.
  • Wuyts FL; Lab for Equilibrium Investigations and Aerospace, University of Antwerp, Wilrijk, Belgium.
Front Neurol ; 15: 1359116, 2024.
Article en En | MEDLINE | ID: mdl-38566854
ABSTRACT

Introduction:

Mal de Debarquement Syndrome (MdDS) is a debilitating neuro-otological disorder. Patients experience almost continuously a perception of self-motion. This syndrome can be motion-triggered (MT-MdDS), such as on a boat, or occur spontaneously or have other triggers (SO-MdDS) in the absence of such motion. Because the pathophysiological mechanism is unknown, treatment options and symptom management strategies are limited. One available treatment protocol involves a readaptation of the vestibular ocular reflex (VOR). This study assesses the effectiveness of vestibulo-ocular reflex (VOR) readaptation in 131 consecutive patients with a fixed protocol.

Methods:

We administered 131 treatments involving optokinetic stimulation (OKS) paired with a fixed head roll at 0.167 Hz over two to five consecutive days. Each day, four-minute treatment blocks were scheduled twice in the morning and afternoon. Treatment effectiveness was evaluated through questionnaires and posturography.

Results:

We observed significant improvements in the visual analog scale (VAS), MdDS symptom questionnaire, and posturography measures from pre- to post-treatment. No significant differences were found in outcome variables between MT- and SO-MdDS onsets.

Conclusion:

Symptoms improved subjectively and objectively in patients' post-treatment. The overall success rate was 64.1%, with no significant difference between MT (64.2%) and SO (63.3%). This study supports the conclusion that VOR readaptation treatment provides relief for two-thirds of MdDS patients, irrespective of the onset type. Based on consistency in the findings, we propose a standardized method for treatment of MdDS based on the OKS with head roll paradigm.
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Front Neurol Año: 2024 Tipo del documento: Article País de afiliación: Bélgica Pais de publicación: Suiza
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Front Neurol Año: 2024 Tipo del documento: Article País de afiliación: Bélgica Pais de publicación: Suiza